Analyst Coverage
|
Peregrine Pharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Peregrine Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Peregrine Pharmaceuticals, Inc. or its management. Peregrine Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. The above may not represent a comprehensive list of analysts choosing to cover Peregrine Pharmaceuticals, Inc.
|
NASDAQ:PPHM
$1.42
+ 0.08
|
Sep 9, 2010
4:00 PM ET |
Quotes delayed at least 20 minutes. Information provided by eSignal.
|
|